UNSPSC 51182079: Trenbolone cyclohexylmethylcarbonate

This classification denotes an anabolic steroid with the molecular formula C26H34O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BNJ7Y3JFF2, chemically known as estra-4,9,11-trien-3-one, 17-(((cyclohexylmethoxy)carbonyl)oxy)-, (17.beta.)-, but more generally known as trenbolone cyclohexylmethylcarbonate, which bears US NIH Compound Identifier 90930. European Medicines Agency schedules trenbolone cyclohexylmethylcarbonate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11232MIG.

Most nations, for tariff purposes, schedule trenbolone cyclohexylmethylcarbonate under HS 29372900. SMILES: C[C@]12C=CC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2OC(=O)OCC5CCCCC5.

UNSPSC 51182079 Trenbolone cyclohexylmethylcarbonate is a Commodity code identifying a controlled anabolic steroid compound. State and local procurement activity under this code is minimal to nonexistent; no recent state or local government opportunities appear in the available record for this substance. The code nominally covers a Schedule III pharmaceutical ingredient used in veterinary medicine and regulated under the Controlled Substances Act, yet state and local procurement systems rarely solicit it directly through open competition, and when they do, the activity is sparse and episodic. Issuing bodies that might engage with this compound—animal control agencies, veterinary services divisions within state agriculture departments, or research institutions—typically source it through restricted channels, existing vendor relationships, or standing agreements with licensed pharmaceutical distributors rather than through public RFP, RFQ, IFB, or ITB processes.

The geographic spread and recent opportunity landscape for this code cannot be characterized from available data, as no representative recent solicitations from state or local jurisdictions are present in the record. A business development professional evaluating pursuit under this code should confirm whether relevant issuing bodies in target geographies are actually conducting open procurements for this substance, as the absence of visible recent activity may indicate that procurement occurs through alternative contracting vehicles, standing state contracts, or that demand is too infrequent to support routine market engagement.